MedPath

PULMOZYME

PULMOZYME

Approved
DIN Number

02046733

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

Hoffmann-La Roche Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02046733
AIG Number0124648001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
R05CB13 DORNASE ALFA (DESOXYRIBONUCLEASE)
Product Specifications
Dosage FormSolution
Route of AdministrationInhalation
AHFS Classification48:24.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DORNASE ALFAActive
Strength: 1 MG / ML
Monograph: DORNASE ALFA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.